Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACE pharmacokinetic study of aprepitant added to cisplatin-etoposide in metastatic lung carcinoma
2007-003347-73Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of aprepitant, etoposide and cisplatin in bronchial carcinoma and chemotherapy-induced nausea and vomiting (CINV) (2 arms), sponsored by Radboud University Medical Center. Started Aug 2007; status: completed.
02
Drugs
aprepitantetoposidecisplatin
03
Conditions
bronchial carcinomachemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on 2007-003347-73.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003347-73.